Fundraising Fox

Amed Ventures β€” Full Portfolio

11 tracked investments Β· listed companies and verified rows first

Atia Accommodating intraocular lens replacementatiavision.cominβœ“ verified

Atia Vision develops OmniVu, a modular shape-changing dual-optic intraocular lens (IOL) that uses the eye's natural accommodative mechanism to restore near, intermediate, and distance vision for cataract patients.

HardwareHealthtechMedical DevicesCampbell, US

Co-investorsThe Capital PartnershipDelos Capital

Supira Medicalsupiramedical.cominNov 2023 Β· $40Mβœ“ verified

Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) to provide temporary mechanical circulatory support for high-risk patients undergoing coronary interventions and those in cardiogenic shock.

HardwareHealthtechMedical DevicesCampbell, US

Nitin Salunke(President & CEO)inJean Orth(Executive Officer)Mariam Maghribi(Executive Officer, Director)

BoardCasey Gordon(Director)Christopher Shen(Director)Bihua Chen(Director)

Co-investors415 CapitalThe Capital PartnershipNovo HoldingsUnorthodox Ventures

Verge Medical Aorto-ostial interventional technologiesostialflash.comβœ“ verified

Verge Medical (formerly Ostial Corporation) develops medical devices for aorto-ostial vascular interventions, including the FLASH Flex aorto-ostial angioplasty system and the RoVo mechanical thrombectomy device, used by physicians for coronary and peripheral vascular cases.

HealthtechMedical Devices

Mike Buck(Chief Executive Officer)inAdam Tschida(General Manager & COO)in

Co-investorsDelos Capital

Proto Laseprotolase.cominNov 2021SEC filingmedium confidence

ProtoLase provides laser processing services for organizations requiring clinical relevance and product efficiency in their manufacturing or product development processes.

Advanced ManufacturingHardwareMedical DevicesMaple Grove, US

DARLENE KIEFER(Chief Financial Officer of Issuer)inBRADY HATCHER(Director and Chief Operating Officer of Issuer)inDARYL KIEFER(Director and Chief Executive Officer of Issuer)in

Board seatYuan Wei TaiΒ· per SEC Form D Β· $3.3M raise Β· filed Dec 2021

Imperativeimperative.comin𝕏Jul 2021 Β· $260M

Chronus is a platform that connects employees for guided, AI-assisted conversations focused on career development, mentoring, community building, and change adoption in enterprise organizations.

AI & Machine LearningEnterprise SoftwareFuture of WorkHR TechSaaSNew York, US

Aaron Hurst(Founder)in

Co-investorsVoyager CapitalAlly Bridge GroupAscension VenturesBain Capital Life SciencesCatalio Capital ManagementDelos Capital+2 more

Neurolutionsneurolutions.cominFeb 2025

Neurolutions makes IpsiHand, an FDA-cleared brain-computer interface system for at-home motor rehabilitation of chronic stroke survivors with arm and hand weakness.

BiotechDigital HealthHealthtechMedical DevicesVan Nuys, US

Eric Leuthardt(Director)inLeo Petrossian(Executive Officer, Director)in

BoardYuanwei Tai(Director)Kevin Reilly(Director)inFred Khosravi(Director)inStavros Vizirgianakis(Director)

Co-investorsAlly Bridge Group

Rejonirejoni.cominSep 2020

Rejoni is a company focused on uterine health, developing technology to address women's reproductive and gynecological health needs.

BiotechFemTechHealthtechMedical DevicesBedford, US

AMARPREET SAWHNEY(Executive Officer, Director, Promoter)inAmar Sawhney(Founder)inNICK SVENCER(Executive Officer, Director, Promoter)FARHAD KHOSRAVI(Executive Officer, Director, Promoter)

BoardTARA BUTLER(Executive Officer, Director, Promoter)

Co-investorsAscension VenturesClavystBioDelos CapitalFemHealth VenturesIyengar Capital PartnersCatalyst Health Ventures

Sealonixsealonix.comMay 2023

Sealonix develops hemostatic sealants based on proprietary biomaterials to control surgical bleeding, targeting surgeons and patients undergoing abdominopelvic and other surgical procedures.

BiotechMedical DevicesNew MaterialsBedford, US

Amarpreet Sawhney(Executive Officer, Director)Amar Sawhney(Founder)

Co-investorsExcelestar VenturesJ2 Ventures

Other

Tracked investments with no reachable website or further public details β€” typically companies that wound down, renamed, or were absorbed.

Base5 GenomicsAkura MedicalOstial

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.